Skip to content

Orphan Drug Development: Medical Marketing Perspective

December 5, 2012

       Medical Marketing & Media’s November 2012 issue has an interesting article titled, “Private View: Orphan Diseases”, by Mike Hodgson, Partner & Chief Creative Officer at Cambridge BioMarketing. Cambridge BioMarketing is a global healthcare marketing and communications agency working with orphan products.         

         Several examples of orphan products and their ads are reviewed in terms of the orphan and rare disease community’s special wants, needs, and requirements :

–  Pfizer’s Benefix for Hemophilia B 

–  Takeda Millennium’s Velcade for cancer 

–   Acorda Therapeutics’ Ampyra for Multiple Sclerosis.

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: